Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 3/2004

01-10-2004

Clinical and Oncologic Implications in Epigenetic Down-Regulation of CD26/ Dipeptidyl Peptidase IV in Adult T-Cell Leukemia Cells

Authors: Tomohiro Tsuji, Kazuyuki Sugahara, Kazuto Tsuruda, Akiko Uemura, Hitomi Harasawa, Hiroo Hasegawa, Yasuaki Yamada, Shimeru Kamihira, Yukio Hamaguchi, Masao Tomonaga

Published in: International Journal of Hematology | Issue 3/2004

Login to get access
Metadata
Title
Clinical and Oncologic Implications in Epigenetic Down-Regulation of CD26/ Dipeptidyl Peptidase IV in Adult T-Cell Leukemia Cells
Authors
Tomohiro Tsuji
Kazuyuki Sugahara
Kazuto Tsuruda
Akiko Uemura
Hitomi Harasawa
Hiroo Hasegawa
Yasuaki Yamada
Shimeru Kamihira
Yukio Hamaguchi
Masao Tomonaga
Publication date
01-10-2004
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 3/2004
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.04066

Other articles of this Issue 3/2004

International Journal of Hematology 3/2004 Go to the issue

OriginalPaper

Cytokine-Mediated Cell Survival

Case Report

Successful Treatment of Tacrolimus (FK506)-Related Leukoencephalopathy with Cerebral Hemorrhage in a Patient Who Underwent Nonmyeloablative Stem Cell Transplantation

Case Report

Successful Unrelated Cord Blood Transplantation Using a Reduced-Intensity Conditioning Regimen in a 6-Month-Old Infant with Congenital Neutropenia Complicated by Severe Pneumonia

Case Report

Humanized Anti-Interleukin 6 Receptor Antibody Induced Long-term Remission in a Patient with Life-Threatening Refractory Autoimmune Hemolytic Anemia

Case Report

Aleukemic Leukemia Cutis in a Patient with Philadelphia Chromosome-Positive Biphenotypic Leukemia

OriginalPaper

Apoptosis of Multiple Myeloma
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits